Antibiotic Resistance Control Program in Pediatric Hematology and Oncology Patients at Dr. Soetomo Hospital in 2006–2007
Downloads
Antibiotic resistance has been increasing since the first years of the clinical usage. It caused by inappropriate usage and uncontrol of antibiotic drugs. Therfore an Antibiotic Resistance Control Program (ARCP) is needed to overcome the problem. The purpose of this study is to know microorganism pattern and evaluate antibiotic use. Phase 1 (before ARCP), retrospective study by medical record of pediatric hematology-oncology patients with suspision of infection and admitted at dr Soetomo Hospital from June–August 2006 was carried out. Phase 2 (during ARCP), a prospective observational study was done from November 2006 to January 2007. We were evaluated the isolated microorganism, quantity of antibiotic were determined by Defined Daily Doses (DDD)/100 patients-days, quality of antibiotics usage were assessed with Glyssen classification, and the cost calculation of antibiotic therapy. Twenty seven patients were enrolled in phase 1 and 28 patients in phase 2. Coagulase-negative Staphylococci and Acinetobacter Sp as isolated microorganism was reported. Phase 1, the most sensitive antibiotic was Cefoperazone-Sulbactam and the most resistant was Penicillin G. Phase 2, Meropenem was the most sensitive antibiotic and Cotrimoxazole was the most resistant antibiotic. The use of antibiotics were decreased 6 vs 12 and DDD/100 patients-days were 14.52 vs 45.04. There were improving of Glyssen classification. The cost calculation of antibiotics therapy were decreased. ARCP can improve antibiotic use in pediatric hematology-oncology patients.
Meningkatkan Kualitas Pelayanan Pasien dan Mencegah Peningkatan
Resistensi Kuman”, Cermin Dalam Kedokteran, Vol. 37, No. 1, 2010, pp. 7–10.
2. A. Sadiumenge, E. Diaz, A. Rodriguez, L. Vidaur, L. Canadell, M.
Olona, "Impact of Diversity of Antibiotic Use on the Development of
Antimicrobial Resistance”, J Antimicrob Chemother, Vol. 57, 2006, pp. 1197–204.
3. EL. Larson, D. Quiros, T. Giblin, S. Lin, "Relationship of Antimicrobial Control Policies and Hospital and Infection Control Characteristic to Antimicrobial Resistance Rates”, Am J Crit Care, Vol. 16, 2007, pp. 110–20.
4. LE. Nicholle, ínfection Control Programmes to Contain Antimicrobial Resistance”, available at www.wpro.who.int, accessed on July 2010.
5. U. Hadi, DO. Duerink, ES. Lestari, NJ. Nagelkerke, S. Werter, M.
Keuter, et al, "Survey of Antibiotic Use of Individual Visiting Public
Healthcare facilities in Indonesia”, available at https://openaccess.
leidenuniv.nl/bitstream/1887/13821/8/03.pdf, accessed on July
2010.
6. IC. Gyssens, PJ. van der Broek, BJ. Kullberg, YA. Hekster, JWM.
Van der Meer, "Optimizing Antimicrobial Therapy. A Method for
Antimicrobial Drug Evaluation”, J Antimicrob Chemother, Vol. 30, 1992, pp. 724–7.
7. MS. Al-ahwal, "Pattern of Febrile Neutropenia in Solid Tumor –
a Hospital based study”, Park J Med Sci, Vol. 21, No. 3, 2005,
pp. 249–52.
8. S. Kannangara, "Management of Febril Neutropenia”, Commun
Oncol, Vol. 3, 2006, pp. 585–91.
9. IC. Gyssen, IEJ. Geerligs, JMJ. Dony, JA van der Vliet, A. van
Kampen, PJ. Van den Broek, et al, "Optimising Antimicrobial drug
Use in Surgery: an Intervention atudy in a Dutch University Hospital”, J Antimicrob Chemother, Vol. 38, 1996, pp. 1001–1012.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
